IRADIMED CORPORATION (IRMD)
NASDAQ: IRMD · Real-Time Price · USD
70.63
-1.00 (-1.40%)
Sep 3, 2025, 4:00 PM - Market closed
IRADIMED CORPORATION Revenue
IRADIMED CORPORATION had revenue of $20.41M in the quarter ending June 30, 2025, with 13.84% growth. This brings the company's revenue in the last twelve months to $77.64M, up 11.73% year-over-year. In the year 2024, IRADIMED CORPORATION had annual revenue of $73.24M with 11.71% growth.
Revenue (ttm)
$77.64M
Revenue Growth
+11.73%
P/S Ratio
11.55
Revenue / Employee
$485,220
Employees
160
Market Cap
898.41M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 73.24M | 7.68M | 11.71% |
Dec 31, 2023 | 65.56M | 12.26M | 23.00% |
Dec 31, 2022 | 53.30M | 11.49M | 27.48% |
Dec 31, 2021 | 41.81M | 10.10M | 31.83% |
Dec 31, 2020 | 31.72M | -6.80M | -17.65% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
IRMD News
- 8 days ago - IRADIMED CORPORATION to Participate in the 2025 Wells Fargo Healthcare Conference - GlobeNewsWire
- 13 days ago - IRadimed: Continued Value Unlock With Extensive Reinvestment Runway - Seeking Alpha
- 4 weeks ago - IRADIMED CORPORATION (IRMD) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - IRADIMED CORPORATION Reports Record Second Quarter 2025 Financial Results - GlobeNewsWire
- 5 weeks ago - IRADIMED CORPORATION to Hold Second Quarter of 2025 Financial Results Conference Call on August 1, 2025 - GlobeNewsWire
- 3 months ago - IRADIMED CORPORATION Announces FDA 510(k) Clearance for MRidium® 3870 Infusion Pump System - GlobeNewsWire
- 4 months ago - IRADIMED CORPORATION (IRMD) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - IRADIMED CORPORATION Announces First Quarter 2025 Financial Results - GlobeNewsWire